Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report

Passarelli, A; Pisano, C; Coppola, E; Ventriglia, J; Cecere, SC; Di Napoli, M; Carideo, L; Lastoria, S; Pignata, S

Passarelli, A (通讯作者),Ist Nazl Tumori Ist Ricovero & Cura Carattere Sci, Dept Urol & Gynecol, Naples, Italy.

FRONTIERS IN IMMUNOLOGY, 2023; 14 ():

Abstract

Cervical cancer (CC) is the second most commonly diagnosed cancer and the third leading cause of cancer death among females. The options of treatment ......

Full Text Link